spinoffs
Agilent and Keysight are great examples of how spinoffs can deliver big returns for growth investors. In the 10 years since Agilent spun off Keysight (shareholders received one Keysight share for every two shares they held), the stock is up 220%, while Keysight has soared 420%....
You Can See Our Spinoff Stock Portfolio For November 2024 Here.
Why we like spinoffs so much
We think that spinoffs are the closest thing you can find to a sure thing for two main reasons:
1) The management of a parent company will only hand out shares in a subsidiary to its own investors if it’s all but certain that business, and the parent, will be better off after the spinoff.
2) Spinoffs involve a lot of work and legal fees....
Build a portfolio of the best stocks worth investing in by taking a diversified approach that includes spotting hidden assets, sustainable dividends, and strong growth prospects
We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. At the same time, over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie—itself a spinoff—has further gains ahead. We recommend this stock as a Power Buy.
ABBVIE INC., $192.94, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $340.8 billion; Dividend yield: 3.2%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.
Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....
ABBVIE INC., $192.94, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $340.8 billion; Dividend yield: 3.2%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.
Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....
You Can See Our Spinoff Stock Portfolio For October 2024 Here.
Why we like spinoffs so much
We think that spinoffs are the closest thing you can find to a sure thing for two main reasons:
1) The management of a parent company will only hand out shares in a subsidiary to its own investors if it’s all but certain that business, and the parent, will be better off after the spinoff.
2) Spinoffs involve a lot of work and legal fees....
Often-overlooked Trisura Group is up a whopping 647.2% since its spinoff from Brookfield and its earnings just shot up a solid 16.1% in the most-recent quarter. It’s a top pick.
MAPLE LEAF FOODS INC. $22 (www.mapleleaffoods.com) is a hold. The company plans to spin off its pork processing business as a separate firm in 2025. It raises and processes hogs and accounts for 32% of Maple Leaf’s total sales....
You Can See Our Spinoff Stock Portfolio For September 2024 Here.
Why we like spinoffs so much
We think that spinoffs are the closest thing you can find to a sure thing for two main reasons:
1) The management of a parent company will only hand out shares in a subsidiary to its own investors if it’s all but certain that business, and the parent, will be better off after the spinoff.
2) Spinoffs involve a lot of work and legal fees....
Many spinoffs tend to move sideways immediately after becoming separate companies. Essentially, it takes time for them to overcome investor reticence to buy. That’s why we don’t yet recommend these two for your new buying.
HOWARD HUGHES HOLDINGS INC....
HOWARD HUGHES HOLDINGS INC....
In general, spinoffs are the closest thing you can find to a sure thing. Study after study has shown that following an initial adjustment period of a few months, spinoffs tend to outperform groups of comparable stocks for several years.
In many cases, we advise investors to not only hold onto their new shares but to add to their position....
In many cases, we advise investors to not only hold onto their new shares but to add to their position....